Methotrexate vs alternative disease‐modifying antirheumatic drugs
Treatment responsea · children and young people with JIA
Methotrexate showed no clear difference in treatment responsea(4 months) compared with alternative disease‐modifying antirheumatic drugs (low certainty).
1 finding from 1 review
- RR 1.4 [0.93, 2.1]1 study · 94 participantsLow